These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
747 related articles for article (PubMed ID: 19775195)
1. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors. Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195 [TBL] [Abstract][Full Text] [Related]
2. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy. Nelson SP; Kothari S; Wu EQ; Beaulieu N; McHale JM; Dabbous OH J Med Econ; 2009; 12(4):348-55. PubMed ID: 19827992 [TBL] [Abstract][Full Text] [Related]
3. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A; Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285 [TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741 [TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and symptom control in patients with GERD: US community-based survey. Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980 [TBL] [Abstract][Full Text] [Related]
6. Development of a refractory gastro-oesophageal reflux score using an administrative claims database. Gerson LB; Bonafede M; Princic N; Gregory C; Farr A; Balu S Aliment Pharmacol Ther; 2011 Sep; 34(5):555-67. PubMed ID: 21714794 [TBL] [Abstract][Full Text] [Related]
7. The economics of laparoscopic Nissen fundoplication. Dire CA; Jones MP; Rulyak SJ; Kahrilas PJ Clin Gastroenterol Hepatol; 2003 Jul; 1(4):328-32. PubMed ID: 15017676 [TBL] [Abstract][Full Text] [Related]
8. A practice-based approach for converting from proton pump inhibitors to less costly therapy. Lucas LM; Gerrity MS; Anderson T Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299 [TBL] [Abstract][Full Text] [Related]
9. Marked increase in proton pump inhibitors use in Australia. Hollingworth S; Duncan EL; Martin JH Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646 [TBL] [Abstract][Full Text] [Related]
10. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. El-Serag HB; Fitzgerald S; Richardson P Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease. Higginbotham TW Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. Kim KM; Cho YK; Bae SJ; Kim DS; Shim KN; Kim JH; Jung SW; Kim N J Gastroenterol Hepatol; 2012 Apr; 27(4):741-5. PubMed ID: 21916988 [TBL] [Abstract][Full Text] [Related]
13. Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population. Doan QV; Lange SM; Elfant A; Aguilar D; Reyes E; Lynn RB; Dubois RW J Med Econ; 2008; 11(1):23-40. PubMed ID: 19450108 [TBL] [Abstract][Full Text] [Related]
14. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease. Williams JF; Sontag SJ; Schnell T; Leya J Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020 [TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease (GERD): is there more to the story? Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011 [TBL] [Abstract][Full Text] [Related]
16. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Gosselin A; Luo R; Lohoues H; Toy E; Lewis B; Crawley J; Duh MS Value Health; 2009; 12(1):34-9. PubMed ID: 19895371 [TBL] [Abstract][Full Text] [Related]
17. A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting. Eloubeidi MA; Homan RK; Martz MD; Theobald KE; Provenzale D Am J Gastroenterol; 1999 Aug; 94(8):2033-6. PubMed ID: 10445524 [TBL] [Abstract][Full Text] [Related]
18. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population. Chan J; Hui RL; Szpakowski JL Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365 [TBL] [Abstract][Full Text] [Related]
19. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. El-Serag HB; Wieman M; Richardson P Aliment Pharmacol Ther; 2008 Jun; 27(12):1293-9. PubMed ID: 18363892 [TBL] [Abstract][Full Text] [Related]
20. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]